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ABSTRACT 
 Upon viral infection, the host’s immune system can induce the antiviral state to 
protect from further infection. In this antiviral state, RNA synthesis and protein synthesis 
are downregulated, and viral replication is inhibited (Kawai and Akira, 2006). Two of the 
key pathways critical to establishing the antiviral state include the Toll-like receptor 
(TLR) and the interferon (IFN) receptor (IFNR) pathways (Kawai and Akira, 2006). The 
TLR pathway is critical to recognizing viral components, while the IFNR pathway is vital 
to activating genes necessary for inducing the antiviral state. As the host evolves to 
combat viral infections, viruses have also evolved to circumvent such host antiviral 
immune response. One viral evasion mechanism is via disruption of cell membrane 
domains known as caveolae. Caveolae membrane domains are critical to maintaining a 
platform from which molecules can signal and have been implicated in a variety of 
disease processes, including breast and prostate cancer, type II diabetes, and 
atherosclerosis (Cohen et al., 2004). 
 Previous studies show that viral infection leads to a downregulation in caveolin 
transcripts and the dispersal of IFNR clusters (Gabor et al., Submitted). As a result, the 
host’s antiviral immune response is dampened. In the present study, I suggest a role for 
caveolae in the TLR9 signaling pathway. Through Fluorescence Photoactivation 
Localization Microscopy (FPALM) imaging, I observe spatial overlap, or colocalization, 
of TLR9 and caveolin molecules. When caveolin is depleted, TLR9 signaling, upon 
exposure to unmethylated CpG DNA, is dampened. Understanding the mechanisms by 
which a pathogen may evade the host’s immune system will provide further insights into 
new and effective treatments, such as IFN and TLR antiviral therapies.
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INTRODUCTION 
 Immunity, or the ability to resist an infection, is composed of two components: 
innate immunity and adaptive immunity (Warrington et al., 2011). Innate immunity is 
present in all organisms and is thus of interest for further research. Part of the innate 
immune response is the induction of the antiviral state, which allows the host to block 
viral replication and subsequently further infection (Kawai and Akira, 2006). Two of the 
key pathways involved in establishing the antiviral state include the Toll-like receptor 
(TLR) pathway and the interferon (IFN) receptor (IFNR) pathway (Kawai and Akira, 
2006). 
 Viruses are intracellular pathogens that depend upon host cell machinery in order 
to replicate and cause infection. While the host has evolved to combat viral infections, 
viruses have also evolved to circumvent the host’s antiviral immune response. Currently, 
there is a heavy emphasis placed on research involving viral evasion of the host’s 
immune system. As a result, intracellular TLRs, such as Toll-like receptor 9 (TLR9), are 
being studied extensively (Blasius and Beutler, 2010).  
 Many viruses have managed to disrupt the innate immune response via disruption 
of IFN signaling (Kawai and Akira, 2006). Recently, our lab has found that one such way 
is via modification of cell membrane domains known as caveolae. Caveolae membrane 
domains have been identified in various tissues and cell types and have been implicated 
in a variety of signal transduction pathways, including β-adrenergic receptors and 
epidermal growth factor receptors (Cohen et al., 2004). In addition, caveolae have been 
suggested to play a role in numerous disease processes, including breast and prostate 
cancer, type II diabetes, and atherosclerosis (Cohen et al., 2004). Thus, these cell 
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membrane domains are targets for further research. Suggesting a role for caveolae in viral 
evasion of the host’s immune system will aid in developing new and effective treatments, 
such as IFN and TLR antiviral therapies. 
 
BACKGROUND 
 If you have the flu, also known as influenza, you will experience symptoms such 
as fever, cough, congestion, aches, and fatigue. When you sneeze or cough, you cover 
your nose and mouth with your hands, hoping to contain the spread of the influenza virus. 
But you are actually spreading it around when you do not wash your hands, and then go 
to touch a doorknob. The next person to touch that doorknob will become exposed to the 
influenza virus.  
 Viruses are prevalent throughout the world and can cause numerous infections 
and diseases. More than 90% of human illnesses may be caused by viral infections, which 
are generally systemic (Norkin et al., 2009). In order to replicate and thus cause further 
infection, viruses require host cell machinery (Garcia-Sastre and Biron, 2006). In healthy 
cells, the host’s immune system can induce the antiviral state through the Toll-like 
receptor (TLR) and the interferon (IFN) receptor (IFNR) pathways (Kawai and Akira, 
2006). In this antiviral state, RNA synthesis and protein synthesis are downregulated and 
thus viral replication cannot proceed (Kawai and Akira, 2006). As a result, viral infection 
is blocked. Recently, our lab has found that upon viral infection, cell membrane domains 
known as caveolae are modified. This allows the virus to evade the host’s antiviral state. 
 Caveolae are cell membrane domains that have been implicated in a variety of 
signal transduction pathways, as well as numerous diseases processes, including breast 
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and prostate cancer, and type II diabetes (Cohen et al., 2004). The organization of these 
cell membrane domains acts as a platform for signaling molecules and is vital to proper 
signaling (Cohen et al., 2004). The role of caveolae during the immune response to viral 
infection is largely unexplored. 
 Performing such studies in the human will give rise to ethical concerns, so I 
employ the zebrafish as a model for human diseases. This aquatic organism is an 
established mainstream model for development, genetics, cancer, infection and immunity, 
but I employ it as a model for human infectious diseases. The zebrafish offers many 
advantages over other common model organisms, including the mouse (Mus musculus) 
and the fruit fly (Drosophila melanogaster) (Lieschke and Currie, 2007). Advantages of 
employing this organism include its small size, short generation time and reproduction 
rate, optical clarity, and the possibility of in vivo real-time imaging host-pathogen 
interactions (Lieschke and Currie, 2007). Like the mouse model, the zebrafish model 
shares many similarities with humans. The zebrafish genome is fully sequenced and there 
are numerous homologous genes (Grunwald and Eisen, 2002).  
 In order to visualize caveolae membrane domains in living systems, Fluorescence 
Photoactivation Localization Microscopy (FPALM) is employed. Conventional light 
microscopy is unable to circumvent the diffraction barrier, which reduces spatial 
resolution (Gabor et al., 2011). FPALM allows imaging of structures that are under 250 
nm in size, such as caveolae, that cannot otherwise be visualized via conventional 
microscopy (Gabor et al., 2011). 
 Previous studies have shown that knockdown of caveolin-1 (Cav-1) leads to a 
dampened antiviral immune response (Gabor et al., Submitted). Viral infection led to 
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dampened cav-1 expression, which resulted in dampened signaling downstream of the 
IFNR pathway. I hypothesize that caveolae may play an important role in the TLR 
pathway. Understanding the mechanisms by which viruses are able to evade the host’s 
antiviral immune response will aid in developing new and effective treatments. IFN and 
TLR antiviral therapies will be aimed at boosting host immunity to viral infections. 
 
VIRUSES 
 Viruses are intracellular 
pathogens composed of 
proteins and nucleic acids. 
They are dependent upon host 
cell machinery, such as 
enzymes, in order to replicate 
and cause further infection 
(Garcia-Sastre and Biron, 
2006). The replication cycle of 
a virus is as follows: entry into 
the cell, manipulation of host 
cell machinery and use of own machinery to replicate its genome and proteins, and exit of 
viral progeny to infect other host cells. This latter step in the cycle usually causes the 
death of the host cell (Garcia-Sastre and Biron, 2006).  
 Viruses are prevalent throughout the world and can cause numerous infections 
and diseases (Fig. 1). They have evolved ways to evade the host’s immune system so 
Fig. 1 Basic overview of viral infections in humans 
(Harvey et al., 2007). 
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understanding how they do this will provide insights into other viral infections, other 
human diseases, and host immunity. Targeted treatments, such as interferon (IFN) and 
Toll-like receptor (TLR) antiviral therapies, will be aimed at boosting host immunity to 
viral infections.  
 
ZEBRAFISH AS A MODEL ORGANISM 
 Model organisms are employed in biomedical research to better understand the 
pathogenesis of human diseases. In recent years, the zebrafish has been established as a 
mainstream model for development, genetics, cancer, infection and immunity. In the 
present study, I employ zebrafish as a model for human infectious diseases.   
 It was not until the late 1960s through the works of George Streisinger that the 
zebrafish was employed as a model for developmental biology and genetics (Grunwald 
and Eisen, 2002). The zebrafish model has been utilized to further our current 
understanding of oncogenesis (Amsterdam et al., 2004), fin regeneration (Huang et al., 
2003), and bacterial infection (Herbomel et al., 1999). 
 Due to genome homology and similarities in anatomy and physiology, the mouse 
(Mus musculus) has become a vital mammalian model organism (Lieschke and Currie, 
2007). But many factors must be taken into consideration when developing such model 
organisms, especially human disease models (Fig. 2). Since there is such functional 
conservation in basic cellular processes in mammals and invertebrates, the disruption of 
these conserved processes can be accurately modeled at a genetic and molecular level in 
the fruit fly (Drosophilia melanogaster) (Lieschke and Currie, 2007). Unfortunately, 
invertebrates lack many structures present in mammals so their role in modeling human 
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diseases is limited (Lieschke and Currie, 2007). Furthermore, the scope of screens that 
are currently performed with invertebrates cannot be duplicated in the mouse without 
exhausting essential resources such as time and money. The zebrafish (Danio rerio) 
provides a solution to this dilemma and serves as a viable vertebrate model system. 
 Some of the attributes of this model organism include external fertilization and 
development, small size (3-5 cm), short generation time (2-4 months), high reproductive 
rate (100-200 embryos per week) and high population density (5 fish/liter) (Meijer and 
Spaink, 2011). Considerable 
genomic resources exist for 
zebrafish through the ongoing 
sequencing of its genome, and 
zebrafish have been demonstrated 
to be amenable to genetic 
manipulation (Lieschke and 
Currie, 2007). The zebrafish also 
provides potential for genomic 
and large-scale mutant analyses. 
 Transgenesis, or the 
process of introducing an 
exogenous gene so the organism 
will express that gene, is possible in the zebrafish. Due to temporal separation of four 
weeks of innate responses from adaptive responses, innate factors involved in pathology 
can be isolated and characterized (Meijer and Spaink, 2011). Perhaps most important is 
Fig. 2 There are many advantages and disadvantages 
to employing certain model organisms for human 
diseases. The zebrafish has been established as an 
excellent model organism for human diseases 
(Lieschke and Currie, 2007).   
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its optical clarity. Zebrafish embryos allow living imaging of important cellular 
processes, including phagocytosis (process by which pathogens are engulfed and 
destroyed) and chemotaxis (Fig. 3) (Meijer and Spaink, 2011). The zebrafish affords the 
ability to image in vivo in real-time the interactions between the host and the pathogen, 
lending a major advantage over other models. Using differential interference contrast 
(DIC) microscopy or transgenic lines with fluorescently marked immune cells and/or 
pathogens, in vivo imaging of host-pathogen interactions in real-time is made possible 
(Meijer and Spaink, 2011). 
 
  
 
 
 
 
 
 There are many advantages to utilizing zebrafish as a model for human infectious 
diseases, but as with any model organism, there are also some problems. Zebrafish must 
be maintained at around 28°C, but human pathogens thrive at 37°C (Lieschke and Currie, 
2007). Therefore, it might be difficult to study some pathogens at this lower temperature. 
To avoid this, fish-specific pathogens could be employed, but such host-pathogen 
Fig. 3 (A) Bright-field view of 48 hour post-fertilization (hpf) zebrafish embryo. (B) 
Confocal image of 48 hpf zebrafish embryo infected with green fluorescent protein 
(GFP)-tagged snakehead rhabdovirus (SHRV). (C) Bright-field view of 48 hpf 
zebrafish embryo infected with red fluorescent protein (RFP)-tagged bacteria ((A & 
B) Courtesy of Kristin A. Gabor; (C) Singer et al., 2010). 
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interactions might be attributed to pathogens that are fish-specific (Lieschke and Currie, 
2007). 
 Due to the attributes previously mentioned, the zebrafish has emerged as an 
excellent model for human infectious diseases and has been established as a model for 
various infectious pathogens, such as Pseudomonas aeruginosa (Phennicie et al., 2010) 
and snakehead rhabdovirus (SHRV) (Phelan et al., 2005). The zebrafish model will 
continue to offer advantages that can work alongside other human disease models.  
Furthering our understanding of these pathologies will not only aid in developing 
effective therapies for a range of human diseases, but also providing insights into fish-
specific diseases and the study of aquaculture (Lieschke and Currie, 2007).   
 
IMMUNITY 
 Like the mouse, the zebrafish shares many similarities with humans. The 
zebrafish genome is fully sequenced and there are numerous homologous genes 
(Grunwald and Eisen, 2002). In addition, a well-developed complement system (a 
pathway that recognizes and opsonizes, or coats, foreign antigens, rendering them 
susceptible to phagocytosis) and conservation in inflammatory proteins have been 
observed in the zebrafish (Meeker and Trede, 2008). Furthermore, there are zebrafish 
homologs of most Toll-like receptors (TLR) (Meeker and Trede, 2008). As a result, the 
zebrafish immune system serves as a strong model of the mammalian immune system. 
 Immunity is composed of two components: innate immunity and adaptive 
immunity (Fig. 4) (Warrington et al., 2011). In order to recognize and subsequently 
eliminate a pathogen, the host must have a strong and properly functioning immune 
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system. The skin, which protects the host from pathogen infiltration, acts as a common 
barrier and precedes the innate immune system (Warrington et al., 2011). In order to 
function properly and efficiently, the host’s immune system must fulfill three 
requirements: (1) recognize a wide, but diverse array of pathogens, (2) rid the host of 
these pathogen once they are recognized by the immune system and (3) differentiate 
between what is self and non-self (Beutler et al., 2004). Failure to accomplish these three 
tasks or a defect in either branch of the immune system may lead to an autoimmune 
disease, an immunodeficiency or a hypersensitivity (Warrington et al., 2011). 
 Whereas the innate immune system is present in all organisms, the adaptive 
immune system is found exclusively in jawed fishes and upper vertebrates (Meeker and 
Trede, 2008). Innate immunity, which is the first line of defense against any infection, is 
non-specific and antigen-independent. Antigens are foreign molecules that may elicit an 
immune response from the host (Warrington et al., 2011). An innate immune response 
Fig. 4 Host immunity is composed of two components: innate immunity and 
adaptive immunity. Innate immunity is the host’s first line of defense against 
any infection. Adaptive immunity may take longer to activate, but it is highly 
specific toward a particular pathogen (Townsend et al., 2008). 
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can occur within minutes or even hours after the initial exposure and there is no 
immunological memory to a particular antigen (Warrington et al., 2011). Adaptive 
immunity, which is antigen-dependent and antigen-specific, is the second line of defense 
against any infection (Warrington et al., 2011). Unlike its innate counterpart, adaptive 
immunity is associated with immunological memory and takes longer to activate 
(Warrington et al., 2011).  
 Adaptive immunity affords some advantages over its innate counterpart, but the 
former also complements the latter. For example, antibodies produced by plasma B cells 
(from the adaptive immune system) aid in opsonizing, or coating, bacteria for destruction 
by innate immune cells (Warrington et al., 2011). Both components of the host’s immune 
system depend upon certain immune cells to phagocytose, or engulf, the pathogen for 
destruction (Warrington et al., 2011). Many of these immune cells arise from myeloid 
progenitors, which include mononuclear and polymorphonuclear phagocytes (Beutler et 
al., 2004). Mononuclear phagocytes include macrophages and dendritic cells, both of 
which originate from monocytes (Beutler et al., 2004). Dendritic cells, which are highly 
efficient at presenting antigens to T cells (from the adaptive immune system), play an 
important role in both immune systems (Beutler et al., 2004). Polymorphonuclear 
phagocytes include neutrophils, basophils, and eosinophils, all of which are vital in 
containing infections (Beutler et al., 2004). To prevent pathogens from causing illness or 
disease, the host must produce these immune cells and a variety of immune proteins, such 
as interferon (IFN).  
 The ultimate goal of innate immunity is to recruit immune cells to sites of 
infection or inflammation through production and distribution of certain proteins 
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involved in cell-cell communication known as cytokines, including IFN (Warrington et 
al., 2011). IFN production leads to the release of antibodies as well as other cytokines and 
proteins, including those of the complement system (Warrington et al., 2011). Binding of 
IFN to its receptor, the IFN receptor (IFNR), ultimately leads to the activation of IFN-
stimulated genes (ISG), which are critical to inducing the antiviral state (Garcia-Sastre 
and Biron, 2006). The innate immune system is also crucial to ridding the body of 
circulating dead cells (Beutler et al., 2004). Furthermore, activating the innate immune 
system may lead to triggering its adaptive counterpart (Beutler et al., 2004). 
 Two of the key pathways of the innate immune system include the Toll-like 
receptor (TLR) and the IFNR pathways (Fig. 5). TLRs are pattern recognition receptors 
(PRR) that recognize conserved motifs known as pathogen-associated molecular patterns 
(PAMP) (Takeshita et al., 2004). The host is able to distinguish between what is self and 
non-self by recognizing these PAMPs, which are only present in the pathogen (Ashkar 
Fig. 5 Two of the key pathways of antiviral innate immunity. Pathway 1, otherwise 
known as the TLR pathway, functions in the initial recognition of the pathogen and is 
critical to the production of IFN. Pathway 2, otherwise known as the IFNR pathway, 
functions in the activation of genes necessary for inducing the antiviral state, including 
IRF7 and Mx (Garcia-Sastre and Biron, 2006). 
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and Rosenthal, 2002). Lipopolysaccharide (LPS) of Gram-negative bacteria is an 
example of a bacterial PAMP (Blasius and Beutler, 2010). Some examples of viral 
PAMPs include nucleic acids, such as dsRNA or unmethylated CpG DNA (Blasius and 
Beutler, 2010). Recognition of PAMPs by PRRs results in downstream signaling, which 
leads to the production of type I IFNs, other inflammatory cytokines, dendritic cell 
maturation, and ultimately the establishment of the antiviral state (Kawai and Akira, 
2006). Binding of IFN to the IFNR initiates the Janus-Kinase-Signal Transducer and 
Activator of Transcription (JAK-STAT) signaling pathway, which is crucial for 
transmitting information from the cell surface into the nucleus (Kawai and Akira, 2006). 
As a result, antiviral genes, such as IFN regulatory factor 7 (IRF7) and Mx, that aid in the 
induction of the antiviral state are activated (Kawai and Akira, 2006). 
 
ANTIVIRAL EVASION 
 Viruses are intracellular pathogens that depend 
upon the cell machinery of the host in order to replicate. 
Therefore, the host’s immune system is critical to 
combating any pathogen it may encounter, including 
viruses. Induction of the antiviral state is a means by 
which the host can block a viral infection (Fig. 6). By 
halting RNA synthesis and protein synthesis, the host 
cell can block viral replication (Kawai and Akira, 
2006). But viruses have evolved ways to evade the 
host’s antiviral immune response. One strategy 
Fig. 6 Induction of the antiviral 
state involves downregulating 
RNA synthesis and protein 
synthesis to block viral 
replication and thus prevent 
further infection (Courtesy of 
Kristin A. Gabor). 
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employed by viruses is to modify specific cell membrane domains known as caveolae. 
Previous studies have shown that interferon (IFN) receptors (IFNR) cluster within these 
caveolae membrane domains (Gabor et al., Submitted). Upon viral infection, caveolin 
transcripts are downregulated, caveolae membrane domains are modified, and clusters of 
IFNRs are dispersed (Gabor et al., Submitted). As a result, downstream signaling is 
dampened and the virus is able to evade the host’s antiviral innate immune response 
(Gabor et al., Submitted). 
 
TOLL-LIKE RECEPTOR (TLR) 9 (TLR9) PATHWAY 
 Organisms have evolved numerous defense mechanisms against a wide array of 
microorganisms prevalent in the environment. One of the key players in the innate 
immune system is the Toll-like receptor (TLR), a family of evolutionarily conserved, 
germ-line-encoded pattern recognition receptors (PRR) (Akira and Takeda, 2004). The 
host’s immune system must not only be able to recognize and eliminate various 
pathogens, but perhaps more importantly, it must be able to distinguish between what is 
self and non-self. This may be achieved through the recognition of conserved molecular 
motifs commonly found in bacteria, viruses, fungi, and other microorganisms, known as 
pathogen-associated molecular patterns (PAMP) (Takeshita et al., 2004). These PAMPs 
are absent from the host and only present in the pathogen (Ashkar and Rosenthal, 2002). 
The TLR pathway is thus crucial to facilitating antiviral signaling upon recognition of 
viral PAMPs. 
 The Toll receptors, initially identified in Drosophila melanogaster, are vital to 
embryological development of the insect as well as its innate immune response against 
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fungal infection (Takeshita et al., 2004). Currently, eleven TLRs have been thoroughly 
characterized in mammals, but more are being further studied (Takeshita et al., 2004). 
Belonging to a family of PRRs, TLRs are type I membrane glycoproteins (Takeshita et 
al., 2004). These membrane receptors may be positioned at the plasma membrane in the 
case of TLR2 and TLR4 or intracellularly, at the endosomal membrane, in the case of 
TLR3, TLR7 and TLR9 (Blasius and Beutler, 2010). Recent studies are focusing 
primarily on the properties and functions of these intracellular receptors (Blasius and 
Beutler, 2010). Each TLR differs from the 
others on the basis of ligand specificity 
and expression pattern (Ashkar and 
Rosenthal, 2002).  
 TLRs consist of an extracellular 
domain (ECD), consisting of fifteen 
leucine-rich repeats (LRR), and a single 
cysteine-rich domain (CRD); a 
transmembrane domain (TMD); an 
intracellular Toll/interleukin (IL)-1 receptor (TIR) domain; and approximately thirty-two 
amino acids at the COOH-terminus that are crucial to the subsequent signal transduction 
pathway (Fig. 7) (Takeshita et al., 2004). 
The LRRs form a horseshoe structure that 
is directly involved in the requisite 
recognition of a pathogen (Akira and 
Takeda, 2004). 
Fig. 7 Structure of a Toll-like receptor (TLR). 
The leucine-rich repeats (LRRs) functions in 
the initial recognition of the pathogen. The 
Toll/interleukin (IL)-1 receptor (TIR) domain 
is crucial to the subsequent downstream 
signaling cascade. TLRs are type I membrane 
glycoproteins (Kuby et al., 2007). 
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 The function of TLRs is highly dependent upon their location within the cell.  
TLRs located at the cell surface, such as TLR2 and TLR4, are recruited to phagosomes 
after ligand binding and activation (Akira and Takeda, 2004). Intracellular TLRs, such as 
TLR9, are initially expressed in the endoplasmic reticulum (ER), but are then recruited to 
endolysosomes after stimulation with the appropriate ligand (Fig. 8) (Blasius and Beutler, 
2010). The ligand for TLR9 is unmethylated CpG DNA (Blasius and Beutler, 2010; 
Takeshita et al., 2004). The 
acidic environment within 
the endolysosomes is 
crucial to the activation of 
intracellular TLRs, since 
compounds that prevent 
acidification, such as 
bafilomycin A1, 
chloroquine and 
ammonium chloride, seem 
to abrogate their responses 
(Blasius and Beutler, 2010). 
Several chaperone proteins 
are required for proper and efficient translocation of intracellular TLRs from the 
endoplasmic reticulum (ER) to the Golgi apparatus and subsequently endolysosomes 
(Blasius and Beutler, 2010). Gp96, PRAT4A, and UNC93B1 are proteins that associate 
with intracellular TLRs in the ER (Blasius and Beutler, 2010). Gp96 is an ER chaperone 
Fig. 8 Processing of various intracellular TLRs. TLR9 
is initially expressed in the endoplasmic reticulum (ER), 
translocates to the Golgi apparatus, and then is modified 
in the endosome by cysteine proteases (Blasius and 
Beutler, 2010). 
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protein for TLRs, as well as immunoglobulin gamma (IgG), and certain integrins (Blasius 
and Beutler, 2010). In macrophages lacking gp96, TLR9 cannot properly recognize or 
respond to unmethylated CpG DNA (Blasius and Beutler, 2010). PRAT4A is required for 
proper translocation of TLR1, TLR2, and TLR4 from the ER to the plasma membrane, as 
well as TLR7 and TLR9 from the ER to the endosome, playing a critical role in the 
functioning of most TLRs (Blasius and Beutler, 2010). UNC93B1, another ER protein, 
also plays a vital role in mediating translocation of intracellular TLRs from the ER to the 
endosomes (Blasius and Beutler, 2010). 
 Upon successful translocation from the ER, part of TLR9 is proteolytically 
cleaved to yield the biologically active product, which is restricted to endosomes (Blasius 
and Beutler, 2010). The full-length version of TLR is found exclusively in the ER 
(Blasius and Beutler, 2010). Proteolytic cleavage of TLR9 is required for proper 
recruitment of the adaptor molecule myeloid differentiation primary-response protein 88 
(MyD88) and subsequent signal transductions, and has been shown to increase binding to 
unmethylated CpG DNA (Blasius and Beutler, 2010). 
 CpG oligodeoxynucleotides (ODN) are synthetic DNA motifs that contain a 
cytosine followed by a guanine and, depending on the particular CpG ODN, a 
phosphodiester or phosphothioate DNA backbone (Ashkar and Rosenthal, 2002). CpG 
ODNs are TLR-specific, stimulating and activating TLR9 only (Ashkar and Rosenthal, 
2002). CpG sites are present in the genome of all organisms, but there are differences 
among vertebrate and microbial CpG DNA (Ashkar and Rosenthal, 2002). In bacteria 
genomes, CpG dinucleotides are found with a frequency of one in every sixteen 
dinucleotides, whereas in vertebrates they are present at only one-fourth the expected 
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frequency (Ashkar and Rosenthal, 2002). In vertebrates, CpG sites are commonly 
preceded by a cytosine and followed by a guanine (Ashkar and Rosenthal, 2002). These 
will not stimulate TLR9 nor elicit an immune response (Ashkar and Rosenthal, 2002). In 
vertebrate DNA, approximately 70% of the cytosines are methylated, while CpG sites in 
bacterial DNA are unmethylated (Ashkar and Rosenthal, 2002). Therefore, unmethylated 
CpG DNA indicates to the host that a foreign pathogen is present (i.e. “non-self”) 
(Ashkar and Rosenthal, 2002). Human embryonic kidney (HEK) 293 (HEK293) cells 
transfected with mouse TLR9 (mTLR9) elicited the appropriate response upon exposure 
to bacterial CpG DNA (Chuang et al., 2002). When exposed to other bacterial PAMPs or 
control methlated CpG DNA, the 
cells were unresponsive (Chuang 
et al., 2002). 
 Upon stimulation of any 
TLR with its appropriate ligand, a 
signal transduction pathway is 
initiated (Fig. 9). Unmethylated 
CpG DNA is the ligand that 
stimulates TLR9 specifically and 
subsequently activates a signal 
transduction pathway that is 
dependent upon MyD88, which has 
two protein interaction domains: an amino-terminal death domain and a carboxy-terminal 
TIR domain (Ashkar and Rosenthal, 2002). Upon ligand binding, TLR9 receptor subunits 
Fig. 9 Intracellular TLR signaling pathway. 
Upon activation of TLR9 by unmethylated CpG 
DNA, a MyD88-dependent signal transduction 
pathway is initiated. IRF7 is activated and type I 
IFNs are produced (Garcia-Sastre and Biron, 
2006). 
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dimerize, which results in the recruitment of MyD88 via the cytoplasmic TIRs of the 
TLRs. (Ashkar and Rosenthal, 2002). Association of the TIR domain of MyD88 with the 
TIR part of the TLRs facilitates association of the death domain of MyD88 with the IL-
1R-associated kinase (IRAK) and recruits IRAK to the receptor complex (Ashkar and 
Rosenthal, 2002). Toll-interacting protein (TOLLIP) can also recruit IRAK to the same 
complex (Ashkar and Rosenthal, 2002). IRAK is autophosphorylated upon reaching the 
receptor complex and eventually dissociates to interact with tumor necrosis factor (TNF)-
receptor-associated factor 6 (TRAF6) (Ashkar and Rosenthal, 2002). TRAF6 induces 
activation of transforming growth factor (TGF)-β activated kinase 1 (TAK1) and 
mitogen-activated protein (MAP) kinase kinase 6 (MKK6), which subsequently activates 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), c-Jun N-terminal 
kinases (JNK) and p38 (a class of MAP kinases), respectively (Ashkar and Rosenthal, 
2002). TRAF6 also recruits ECSIT (evolutionary conserved signaling intermediate in toll 
pathways) and activates activator protein (AP) 1 (AP-1) (a transcription factor) and NF-
κB (a protein complex that controls the transcription of DNA) (Ashkar and Rosenthal, 
2002). 
 In addition, activation of TLR9 leads to the production of type I IFNs (Blasius 
and Beutler, 2010). After binding of unmethylated CpG DNA to TLR9, and upon 
complexing with MyD88, IFN regulatory factor 7 (IRF7) is phosphorylated by 
interleukin-1 receptor-associated kinase 1 (IRAK1) and IRAK4, and translocates into the 
nucleus (Kawai and Akira, 2006). Furthermore, IRF7 activation requires TRAF6 E3 
ubiquitin ligase activity (Kawai and Akira, 2006). Activation of the TLR signaling 
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pathway triggers the IFNR signaling pathway, which ultimately leads to the induction of 
the antiviral state (Kawai and Akira, 2006). 
 
INTERFERON (IFN) RECEPTOR (IFNR) PATHWAY 
 In order to respond to and prevent the propagation of pathogens, the host has 
developed various defense mechanisms, including the production and secretion of 
antimicrobial factors such as interferon (IFN), the first cytokine discovered (Samuel et 
al., 2007). Previous studies found that chick cells infected with the influenza virus 
produced and secreted a factor that seemed to facilitate and promote an antiviral state in 
previously uninfected cells (Isaacs and Lindenmann, 1957). Due to “its ability to interfere 
with virus growth,” the factor was referred to as IFN (Samuel et al., 2007). 
 There are three types of IFN, the first of which (type I) is important in facilitating 
the antiviral state, with IFN-α and IFN-β as key players, but all IFNs are crucial to 
regulating the immune system (Garcia-Sastre and Biron, 2006). Transcription factors, 
such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), c-Jun N-
terminal kinases (JNK), IFN regulatory factor 3 (IRF3) and IRF7, seem to regulate the 
expression of type I IFNs (Kawai and Akira, 2006). In response to the host’s immune 
system, pathogens have evolved countermeasures to dampen such defense mechanisms. 
For example, by inhibiting the production of the above factors, viruses are able to inhibit 
host cellular gene expression (Garcia-Sastre and Biron, 2006). 
 Induction of type I IFNs via TLR9 occurs via MyD88 (MyD88-dependent) in 
association with the Toll/interleukin (IL)-1 receptor (TIR) domain of the TLRs, 
interleukin-1 receptor-associated kinase 1 (IRAK1) and IRAK4, and tumor necrosis 
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factor (TNF)-receptor-associated factor 6 (TRAF6) (Garcia-Sastre and Biron, 2006). As a 
result, IRF7 is activated downstream, in addition to IκB kinase (IKK) α/β/γ and the 
mitogen-activated protein kinases (MAPK) cascades, culminating in the activation of NF-
κB and activator protein (AP) 1 (AP-1) (Garcia-Sastre and Biron, 2006). Production of 
IFN can also be triggered via other pathways independent of the membranous TLRs. 
These cytoplasmic sensors include the retinoic acid-inducible gene I (RIG-I) and the 
melanoma differentiation-associated gene 5 (Mda5) (Garcia-Sastre and Biron, 2006). 
 Regulation of type I IFNs occurs via the type I IFN receptor (IFNR), a cell surface 
transmembrane receptor that is composed of two subunits: IFN-α receptor (IFNAR) 1 
(IFNAR1) and IFNAR2 (Fig. 10) (Garcia-Sastre and Biron, 2006). Binding of IFN to the 
IFNR results in the dimerization of 
receptor subunits and subsequent 
activation of kinases that associate 
with their cytoplasmic tails: the 
Janus-activated kinase 1 (JAK1) and 
tyrosine kinase 2 (TYK2) (Garcia-
Sastre and Biron, 2006). Next, 
tyrosine phosphorylation activates 
the signal transducers and activators 
of transcription 1 (STAT1) and 
STAT2 to form a trimeric STAT1-
STAT2-IRF9 complex, otherwise 
known as IFN-stimulated gene factor 3 (ISGF3) (Garcia-Sastre and Biron, 2006). These 
Fig. 10 After IFN is produced from the TLR 
signaling pathway, it can bind to IFNRs on 
neighboring cells to activate the IFNR signaling 
pathway. This second pathway leads to the 
activation of genes critical for the induction of the 
antiviral state (Garcia-Sastre and Biron, 2006). 
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complexes translocate to the nucleus and ultimately bind to DNA regulatory sequences 
containing IFN-stimulated response elements (ISRE) (Garcia-Sastre and Biron, 2006). As 
a result, hundreds of IFN-stimulated genes (ISG) are transcribed, and the antiviral state is 
established (Garcia-Sastre and Biron, 2006). 
 
CELL MEMBRANES 
 The previous fluid mosaic model posited that peripheral and integral proteins float 
and diffuse throughout the plasma membrane (Singer and Nicolson, 1972). However, a 
recent hypothesis proposes that proteins are distributed and clustered within membrane 
domains known as lipid rafts (Fig. 11) (Cohen et al., 2004). 
  
 These lipid rafts are rich in glycosphingolipids, sphingomyelin and cholesterol 
(Chidlow and Sessa, 2010). Studies have implicated lipid rafts in the assembly and 
budding of several enveloped viruses, such as influenza virus (Ravid et al., 2010). 
Caveolae are morphologically distinct cell membrane domains with similar composition 
to lipid rafts. These membrane domains are formed via the aggregation of sphingolipids 
and sphingomyelin in the Golgi apparatus and then transported to the plasma membrane 
(Cohen et al., 2004). The organization of lipid rafts and caveolae may play an important 
Fig. 11 Cell membrane domains known as lipid rafts are regions where receptors may be 
clustered. This clustering may be vital for efficient signal transduction pathways 
(Courtesy of Kristin A. Gabor). 
22 
 
 
role in the function of membrane receptors as they are concentrated or segregated 
(Chidlow and Sessa, 2010). Caveolae is of interest because it has been linked to various 
signal transduction pathways, and ultimately, human disease processes, including breast 
and prostate cancer, type II diabetes, and atherosclerosis (Cohen et al., 2004). 
 
CAVEOLAE MEMBRANE DOMAINS 
 Caveolae are cell membrane domains that are similar to lipid rafts yet have a 
unique morphology (Fig. 12) (Chidlow and Sessa, 2010). These structures are 
characterized by their omega-like shape in the membrane and are approximately 50-100 
nm in diameter (Cohen et al., 2004). Invagination of the plasma membrane occurs 
through a largely unknown process (Cohen et al., 2004). In terms of tissues and cell 
types, caveolae are ubiquitous and can be found in endothelial and epithelial cells, 
adipocytes, and both striated and smooth muscle cells (Cohen et al., 2004). Their tissue 
and cell type ubiquity make caveolae of particular interest for further research. 
  
Fig. 12 Caveolae membrane domains. Caveolin-1 (shown in red) is a major structural 
protein that directs signaling molecules to caveolae. Invagination of the plasma 
membrane occurs through a largely unknown process (Courtesy of Kristin A. Gabor). 
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Caveolae are further distinguished from lipid rafts by the presence of the 
caveolin-1 (Cav-1) protein (~22 kDa) (Cohen et al., 2004). Cav-1 is a major structural 
component and functions as a scaffolding protein that directs signaling molecules to 
caveolae (Gadjeva et al., 2010). Clathrin-independent endocytosis and regulation of 
intracellular signaling pathways are two processes that depend upon caveolae and 
caveolin (Ravid et al., 2010). 
 Cav-1 belongs to the caveolin gene family, along with cav-2 and cav-3, all of 
which encode 20-24 kDa proteins (Ravid et al., 2010). Cav-1 has been shown to interact 
directly with Cav-2 in the endoplasmic reticulum (ER) to form hetero-oligomeric 
complexes that target lipid rafts and drive the formation of caveolae membrane domains 
(Ravid et al., 2010). Cav-1 homo-oligomerizes into structures of ~400 kDa (Gadjeva et 
al., 2010). Little is known about Cav-2 except that it is co-expressed and dependent upon 
Cav-1, and is alone insufficient to induce caveolae biogenesis (Cohen et al., 2004). By 
forming hetero-oligomeric complexes with Cav-1, Cav-2 has been suggested to play a 
vital role in proper caveolae membrane domain assembly (Chidlow and Sessa, 2010). In 
addition, Cav-2 may regulate the number of caveolae membrane domains (Chidlow and 
Sessa, 2010). Unlike Cav-1 and Cav-2, which are expressed nearly ubiquitously, Cav-3 is 
specific to muscle cells (Cohen et al., 2004). 
 The importance of caveolae can be illustrated through cav knockout experiments. 
For example, knockout of cav-1 expression results in the loss of caveolar structures 
(Cohen et al., 2004). While mice deficient in caveolin may be viable, knockout of Cav-1, 
Cav-2, or Cav-3 leads to different phenotypes (Gadjeva et al., 2010). In contrast, 
knockout of Cav-1 in the zebrafish leads to developmental abnormalities and even death 
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(Frank and Lisanti, 2006). For example, it has been shown that knockdown of Cav-1 in 
zebrafish leads to the disruption of neuromast maturation (Nixon et al., 2007). Depletion 
of caveolin leads to noticeable and dramatic defects in neural and eye development and 
organogenesis (Fang et al., 2006); recent studies have produced similar results (Nixon et 
al., 2007). Interestingly, exogenous expression of cav-1 will induce formation of caveolae 
in cells lacking both caveolae and Cav-1 (Gadjeva et al., 2010). Furthermore, Cav-1 has 
two isoforms, but previous studies have shown that Cav-1a and Cav-1b have non-
redundant roles in the zebrafish (Fang et al., 2006). The role of Cav-1 during the immune 
response to viral infection is largely unexplored. 
 
GENETIC MANIPULATION USING MORPHOLINO OLIGONUCLEOTIDES 
(MO) 
 Genetic manipulation is an important cornerstone of research in the realm of 
genetics and developmental biology. Reverse genetics allows for the study of the normal 
biological function of a gene by manipulating the action of that gene of interest during 
development (Eisen and Smith, 2008). On the other hand, forward genetics is concerned 
with the study of a particular phenotype and determining the genetic basis for that 
phenotype (Lieschke and Currie, 2007).  
 The most widely used reverse genetics antisense technique employed for gene 
knockdown in the zebrafish are morpholino oligonucleotides (MO). Developed by Dr. 
James Summerton, MOs (antisense) were first targeted to inhibit translation of mRNA 
(sense) in vivo (Bill et al., 2009). Similar to DNA and RNA oligomers, MOs are 
composed of 25 morpholine bases [O(CH2CH2)2NH] (Bill et al., 2009). More 
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importantly, MOs are capable of undergoing Watson-Crick base pairing (Eisen and 
Smith, 2008). A neutrally charged phosphorodiamidate backbone gives rise to a high 
binding affinity for RNA and aids in steric hindrance (Bill et al., 2009). Unlike DNA and 
RNA, MOs do not carry an overall negative charge, making them less likely to interact 
non-specifically with other cellular components (Eisen and Smith, 2008). As a result, 
MOs are resistant to nucleases and are thus stable (Eisen and Smith, 2008). 
 There are two types of MOs: splice blocking and translational blocking (Fig. 11). 
Splice blocking MOs inhibit components of the spliceosome, a protein complex that 
removes introns from pre-mRNA (Bill et al., 2009). Translational blocking MOs bind to 
complementary mRNA sequences and prevent proper assembly of the ribosomal complex 
(Bill et al., 2009). Certain assays could be performed to quantify the efficiency of MO 
knockdown, such as reverse transcription polymerase chain reaction (RT-PCR) in the 
case of splice blocking MOs or a western blot in the case of translational blocking MOs.  
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Both splice blocking and translational blocking MOs inhibit zygotic transcripts, 
but the latter can inhibit maternal transcripts as well (Bill et al., 2009). Typically, MOs 
are introduced into 1-8-cell-staged zebrafish embryos, but my experiments are focused on 
the 1–2-cell stage (Bill et al., 2009). This allows for the rapid diffusion of MOs through 
the early embryonic cells, resulting in ubiquitous delivery.  
 Since MOs are fairly new genetic manipulation techniques, there are some 
important matters to keep in mind. An important concern when employing MOs is the 
control. Perhaps the most reliable control in any MO experiment is to attempt to “rescue” 
the phenotype by introducing the gene product of interest in a form that is unaffected by 
the MO (Eisen and Smith, 2008). A common rescue technique is to inject mRNA at the 
1-cell stage (Eisen and Smith, 2008). When employing a translational blocking MO, 
removing the 5’ untranslated region (UTR) of the mRNA or introducing silent mutations 
Fig. 13 Gene knockdown technique utilizing MOs. (A) Structure of a MO, which shares 
similarities to DNA and RNA oligomers. (B, C, D) Splice blocking MO mechanism. (E, 
F) Translational blocking MO mechanism (Bill et al., 2009). 
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into the coding region should rescue the phenotype (Eisen and Smith, 2008). Simply 
injecting mRNA when employing a splice-blocking MO should rescue the phenotype as 
well (Eisen and Smith, 2008).  
 The efficacy of MO knockdown varies with each MO since they are sequence 
specific, so the amount and duration of knockdown is variable (Bill et al., 2009). Thus, 
MO knockdowns and other genetic manipulation techniques have allowed the discovery 
of certain genes in screens, the identification of gene function, and the verification of 
certain mutant phenotypes (Bill et al., 2009). 
 
FLUORESCENCE PHOTOACTIVATION LOCALIZATION MICROSCOPY 
(FPALM) 
 With the advent of light microscopes came important biological discoveries, but 
the laws of diffraction limit the resolution of light microscopy techniques. Diffraction is 
the scattering of light, and molecules that are close together appear blurred as a result of 
this property (Gabor et al., 2011). With light microscopes, many molecules are visible at 
a given time, leading to blurred images. In the 19
th
 century, Ernst Abbe determined that 
the smallest features that could be imaged in a light microscope are about 200-250 nm for 
visible light (Hess et al., 2009). But much of science, especially biology, occurs at 
cellular and molecular levels. Electron microscopy allows for imaging on a smaller, more 
relevant scale, but living specimens cannot be imaged. This prompted the search for an 
alternative microscopy technique (Fig. 14).  
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To improve resolution, localization (determination of position) microscopy 
combines the physics of light with the imaging of single molecules through 
photoactivatable and photoswitchable fluorescent proteins or probes (PAFP) (Hess et al., 
2009). PAFPs differ from conventional fluorescent probes in being non-fluorescent or 
inactive in the sample being imaged until they are photoactivated by a certain wavelength 
of light (Gould et al., 2009).  
 Localization microscopy circumvents the diffraction limit set by the Rayleigh 
criterion (R0=0.61λ/NA, where λ is the wavelength of detected light and NA is the 
numerical aperture) by not visualizing all molecules at once (Gould et al., 2009). 
According to the Rayleigh criterion, objects that are closer together than this given 
distance (~200-250 nm) are unresolved. By imaging a small subset of molecules 
separately, each molecule can be distinguished from the others (Fig. 15) (Hess et al., 
2009). These subsets are activated randomly by illuminating the sample with a 
wavelength of light (activation laser) that is able to switch the PAFPs from inactive or 
invisible into an active or visible state. Using a second wavelength of light (readout 
laser), the activated molecules can be excited, resulting in the emission of fluorescence, 
Fig. 14 (A) Conventional confocal image of a fibroblast cell. (B) FPALM image of a 
fibroblast cell (Hess et al., 2007). 
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which can be imaged by a high-sensitivity camera. The position of each fluoresced 
molecule can then be determined, or localized. For a short period of time, the molecules 
remain visible, but photobleach, or lose fluorescence, under the high-intensity 
illumination (Hess et al., 2009). These repeated cycles of activation, imaging, localization 
and photobleaching allow for the collection of data consisting of thousands of molecules 
and the ultimate generation of an image. Once the molecules have been localized, these 
positions can be plotted and compiled to obtain the desired image (Hess et al., 2009). 
Utilizing these PAFPs and adjusting the rates of photoactivation and photobleaching 
allow the user direct optical control over the number of fluorescent molecules at a given 
time (Gabor et al., 2011). The activation laser is used to control the density of visible 
molecules so that individual molecules can be identified and localized, while the readout 
laser is used to collect the fluorescence from the activated molecules (Gabor et al., 2011). 
 Three localization microscopy methods were introduced in 2006—Fluorescence 
Photoactivation Localization Microscopy (FPALM) (Hess et al., 2006), Photoactivated 
Localization Microscopy (PALM) (Betzig et al., 2006) and Stochastic Optical 
Reconstruction Microscopy (STORM) (Rust et al., 2006). These microscopy techniques 
now allow for imaging in living cells and for imaging multiple-probe-labeled species as 
well as three-dimensional samples (Hess et al., 2009). The probes in each of these 
microscopy techniques allow for the control of the number of fluorescent molecules 
visible at a single time by adjusting the rates of photoactivation and photobleaching  
(Gabor et al., 2011). The length-scale of resolution with features smaller than 200-250 
nm can be achieved with localization microscopy by about tenfold, with FPALM 
achieving approximately 20-30 nm lateral resolution. 
30 
 
 
 Although these techniques have contributed a great deal to improving resolution 
in the realm of microscopy, there still remain limitations, such as the shortage of suitable 
PAFPs. For example, PAFPs need to be invisible before they can be activated. Upon 
activation by the appropriate laser, a large number of photons must be emitted over a 
short amount of time. In order to be read as single molecules, the photons need to be 
quickly imaged. These restrictions limit the supply of suitable PAFPs (Hess et al., 2009). 
Also, the number of genetically encoded PAFPs is small compared to that for standard 
fluorescence imaging (Hess et al., 2009). Another important limitation is the tradeoff 
between spatial and temporal resolution. Minimization of background is crucial both for 
identification of fluorescent probe molecules, and for maximization of the localization 
precision (Hess et al., 2009). 
 FPALM and related super-resolution localization microscopy techniques will 
continue to offer advantages over conventional light microscopy, and will prompt interest 
for further research. Although there still remain limitations, FPALM offers a novel 
alternative to conventional light and electron microscopy techniques. Just as with 
conventional light microscopes, the advent of FPALM will offer many important 
biological discoveries. 
 
PREVIOUS STUDIES 
 Previous studies have shown that knockdown (KD) of caveolin-1 (Cav-1) 
transcripts led to a dampened antiviral response (Gabor et al., Submitted). A microarray 
was performed to examine the global gene regulation of the zebrafish upon infection with 
snakehead rhabdovirus (SHRV). Cell membrane proteins were of interest because Toll-
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like receptors (TLR) and interferon (IFN) receptors (IFNR) are membranous receptors. 
Data from the microarray revealed that caveolin-1 (Cav-1) is downregulated upon viral 
infection, and is thus a molecule of interest. 
  Infection with SHRV, a genus of the family Rhabdoviridae, leads to a dampening 
in overall IFN activity, as a result of caveolin depletion and thus disruption of caveolae 
membrane domains. Further studies show that caveolae play an important role in the 
clustering of IFNR molecules to ensure proper signaling responses. Whole virus 
infections have been shown to alter Cav-1 clustering and dampen downstream IFNR 
signaling. Since there was a dampening in overall IFN activity, I hypothesize that 
caveolae may also have an upstream function in TLR signaling, playing a similar role in 
the clustering of TLRs to maintain efficient signal transductions. 
 
MATERIALS AND METHODS 
Cell culture, constructs and transfections. 
Cell Culture. Zebrafish liver (ZFL) cells were maintained at 28°C, 0% CO2 in leukocyte 
depletion filter (LDF) cell culture medium (50% Leibovitz’s L-15, 35% Dulbecco’s 
modified Eagle’s, and 15% F-12) supplemented with heat-inactivated fetal bovine serum. 
Constructs. pcDNA3.1 TLR9 and pcDNA3.1 Cav-1b constructs were isolated via an 
Endotoxin-Free Plasmid Isolation Miniprep Kit (Omega). Plasmids were linearized to 
allow for the insertion of the photoactivatable fluorescent probes (PAFP). The restriction 
enzymes KpnI and EcoRV linearized TLR9 to allow for the insertion of dendra2. The 
restriction enzymes KpnI and EcoRI linearized Cav-1b to allow for the insertion of PA-
mCherry. 
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Nucleofection for Imaging. Zebrafish liver (ZFL) cells were grown to approximately 80% 
confluency and then washed with phosphate buffered saline (PBS). The cells were 
subsequently trypsinized and re-suspended in leukocyte depletion filter (LDF) cell culture 
medium before being concentrated via centrifugation at 90xg for 10 min. The supernatant 
was removed and the cell pellet was re-suspended in Cell Line 96-well Nucleofector 
Solution (Lonza). A total of 250 ng of DNA for each of the constructs of TLR9 and Cav-
1b were added to 1.6x10
7
 cells in 20 μl/well in a 96-well transfection module (Lonza). 
Cells were electroporated using the Nucleofector 96-well Shuttle System (Lonza) and 
allowed to recover for 10 min at room temperature before resuspension in 80 μl of LDF 
media. Transfected cells (20 μl/construct) were then plated into 96-well plates containing 
180 μl of LDF media. Cells were maintained for 24 hr at 28°C before imaging. 
Nucleofection for Assaying. For Dual-Luciferase Reporter Assay, zebrafish liver (ZFL) 
cells were grown to approximately 80% confluency and then washed with phosphate 
buffered saline (PBS). The cells were subsequently trypsinized and re-suspended in 
leukocyte depletion filter (LDF) cell culture medium before being concentrated via 
centrifugation at 90xg for 10 min. The supernatant was removed and the cell pellet was 
re-suspended in Cell Line 96-well Nucleofector Solution (Lonza). A total of 250 ng of 
DNA for each of the constructs (TLR9 and Cav-1b), 250 ng of IFN-luc, and 6.25 ng of 
pRL-CMV were added to 1.6x10
7
 cells in 20 μl/well in a 96-well transfection module 
(Lonza). Cells were electroporated using the Nucleofector 96-well Shuttle System 
(Lonza) and allowed to recover for 10 min at room temperature before resuspension in 
180 μl of LDF media. Cells were plated in triplicate in a 96-well plate.  Cells were 
maintained for 24 hr at 28°C before assaying. 
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Morpholino Oligonucleotide (MO) Knockdown. 
Cav-1b MO. In order to access the extent of IFN induction via TLR9 as a result of 
caveolin depletion, a Cav-1b MO must be employed. A control MO was also utilized to 
ensure that the effects of IFN induction were a result of Cav-1b knockdown only and not 
a result of the MO being transfected. A previously characterized Cav-1b MO was used as 
described by (Fang et al., 2006), and co-transfected with TLR9 construct (Amaxa). 
Dual-Luciferase Reporter Assay. 
Cells were transfected as described above and maintained for 24 hr at 28°C before 
assaying. Subsequently, cells were exposed to CpG 1668 at 1 μM for 8 hr. Following 
exposure, cells were gently washed with 100 μl Dulbecco’s phosphate buffered saline 
(PBS). Rinse solution was removed before applying 1x Passive Lysis Buffer (PLB). PLB 
(40 μl) was added to zebrafish liver (ZFL) cells before the 96-well plate was placed on a 
Gyrotory Shaker (Model G-2) for 15 min at 150 rpm. After the allotted time, the cell 
monolayer was disrupted by gently scraping the bottom of the wells. Cell lysate (20 μl) 
was added to a white half-volume 96-well plate. Firefly and Renilla luciferase activity 
was measured using the Dual-Luciferase Reporter Assay system (Promega). Relative 
luminescence units (RLU) were measured in a GLOMAX luminometer (Promega). 
Single-Molecule Microscopy. 
Single-color FPALM imaging and analysis. Single-color FPALM imaging was performed 
as described by (Gould et al., 2009; Hess et al., 2009). Two lasers at different 
wavelengths were used for activation (405 nm) and readout (556 nm). Cells were selected 
for FPALM imaging by searching for green fluorescence (TLR9-dendra2). Analysis was 
performed using custom software (Matlab). 
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Two-color FPALM imaging and analysis. Two-color FPALM imaging was performed as 
described by (Gunewardene et al., 2011). Two lasers at different wavelengths were used 
for activation (405 nm) and readout (556 nm). Cells were selected for FPALM imaging 
by searching for green fluorescence (TLR9-dendra2) and red fluorescence (Cav-1b-PA-
mCherry). Analysis was performed using custom software (Matlab). 
Pair correlation calculations. Pair correlation calculations of single-color and two-color 
FPALM were performed using custom software (Matlab). The g(r) value estimates the 
density at a distance r from a given molecule and compares it to a random distribution. A 
g(r) value equal to one indicates a sample with uniform distribution. A g(r) value greater 
than one indicates dense regions of clustering. A g(r) value less than one indicates a de-
clustered sample. This g(r) value allows for the quantification of clustering that may be 
observed in a given sample. 
 
RESULTS 
TLR9 has two caveolin-binding motifs. Most caveolae-associated proteins contain a 
certain caveolin-binding motif. Upon isolation via an Endotoxin-Free Plasmid Isolation 
Miniprep Kit (Omega), samples of TLR9 were sent for genomic sequencing. After 
analysis, two related caveolin-binding motifs (ΦXΦXXXXΦ and ΦXXXXΦXXΦ, where 
Φ is aromatic amino acid Trp, Phe, or Tyr) were elucidated for TLR9 (Fig. 15). One of 
these caveolin-binding motifs (FYFSMWHF) resides between two LRR domains in the 
TLR9 transcript. The other motif (FLFPKFKY) resides in the TIR domain of TLR9. It is 
also known from in vitro studies that aromatic residues (Trp, Phe, or Tyr) are required for 
the proper recognition of the caveolin-binding motif. This would suggest a role for 
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caveolin in the TLR9 signaling pathway. 
 
 
Rab7 colocalizes with TLR9 in the zebrafish. To test whether TLR9 was located 
intracellularly in the endosomes, zebrafish liver (ZFL) cells were co-transfected with 
Rab7-PA-Cherry and TLR9-dendra2. Rab7 is a late endosomal marker protein. (Fig. 16) 
are confocal images of ZFL cells fixed in 3.6% paraformaldehyde 24 hr post-transfection. 
These genetic PAFPs were utilized to test whether TLR9 would still localize properly, as 
the same constructs were employed for single-color and two-color FPALM experiments. 
Regions of yellow indicate spatial overlap, or colocalization, of Rab7 and TLR9 
molecules. This confirms that TLR9 is indeed located in the endosome of zebrafish. 
Fig. 15 Amino acid sequence of TLR9. TLR9 has two caveolin-binding motifs. The 
sequences highlighted in yellow are the caveolin-binding motifs that were elucidated 
upon analysis of the amino acid sequence of TLR9. 
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TLR9 clusters in the endosome of zebrafish. After confirming that TLR9 is located in 
the endosome, the next step was to determine whether TLR9 forms clusters in the 
endosome using FPALM imaging. By overexpressing TLR9 in zebrafish liver (ZFL) 
cells, clusters of TLR9-dendra2 molecules (shown in white boxes) could be seen through 
single-color FPALM imaging (Fig. 17). There are 1573 molecules present. Pair 
correlation analysis generated a g(r) value of 2.4, indicating that molecules are clustered. 
Fig. 16 Confocal images of ZFL cells co-transfected with Rab7, a late endosomal 
marker protein, and TLR9. (A) Regions of yellow indicate spatial overlap, or 
colocalization, of Rab7 and TLR9 molecules. (B) TLR9-dendra2 molecules. (C) 
Rab7-PA-mCherry molecules. (D) Bright-field view of ZFL cells, confirming 
colocalization of Rab7 and TLR9 in the endosome of zebrafish. Scale bar: 20 μm.  
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Fig. 17 TLR9 clusters in the endosome of zebrafish. Single-color FPALM image of 
TLR9-dendra2 overexpressed in ZFL cells. Clustering of TLR9 molecules is apparent 
(shown in white boxes). Statistical analysis generated a g(r) value of 2.4, indicating that 
molecules are not randomly distributed, and instead are clustered. Scale bar: 1 μm. 
 
TLR9 and caveolin colocalize in the endosome of zebrafish. Upon confirming that 
TLR9 is localized in the endosome and that TLR9 clusters, colocalization between TLR9 
and caveolin (shown in white boxes) was demonstrated. By performing two-color 
FPALM imaging, clusters of TLR9-dendra2 and Cav-1-PA-mCherry could be seen (Fig. 
18). This would suggest a role for caveolin in the TLR9 signaling pathway. Pair 
correlation analysis generated a g(r) value of 1.6, indicating that molecules are clustered 
and colocalize. 
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Fig. 18 TLR9 and caveolin colocalize in the endosome of zebrafish. Two-color FPALM 
image of ZFL cells overexpressing TLR9-dendra2 and Cav-1-PA-mCherry. Regions of 
yellow indicate colocalization of TLR9 and Cav-1 molecules (shown in white boxes). 
Statistical analysis generated a g(r) value of 1.6, indicating that molecules are not 
randomly distributed, and instead are clustered and colocalize. Scale bar: 1 μm. 
 
Induction of IFN is dampened as a result of depleting caveolin. Since TLR9 and 
caveolin colocalize in the endosome of zebrafish, the effect of depleting caveolin on IFN 
induction via TLR9 was ascertained by performing a Dual-Luciferase Reporter Assay in 
ZFL cells overexpressing TLR9. Through the luciferase assay, induction of IFN promoter 
activity was quantified. By stimulating TLR9 with the target ligand CpG 1668 at 1 μM, 
IFN promoter activity could be induced. Compared to control ZFL cells, the extent of 
IFN activity in caveolin-depleted ZFL cells is dampened (Fig. 19). p<0.01. 
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Fig. 19 Induction of IFN is dampened as a result of depleting Cav-1. Dual-Luciferase 
Reporter Assay was performed with the IFN promoter as the gene of interest so IFN 
activity could be quantified. TLR9 was stimulated with CpG 1668 at 1 μM. Compared to 
control ZFL cells, the extent of IFN activity in caveolin-depleted ZFL cells is dampened. 
p<0.01. 
 
 
DISCUSSION 
 Viruses are prevalent throughout the world and can cause numerous diseases and 
illnesses. Our lab is interested in innate immunity and related signal transduction 
pathways. Employing the zebrafish as a model for human infectious diseases and 
understanding how pathogens are able to circumvent the host’s immune system will aid 
in developing new and effective treatments against infections. But in the present study, I 
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focus attention on zebrafish liver (ZFL) cells. These are initial experiments and these 
processes need to be examined in vitro in cell culture before they can be studied in vivo.   
 Previous studies show that upon viral infection, caveolin transcripts are 
downregulated, caveolae membrane domains are disrupted, and thus clusters of IFN 
receptors are dispersed (Gabor et al., Submitted). As a result, downstream signaling of 
the IFNR pathway is abrogated and host antiviral immune response is dampened. I want 
to identify a role for caveolin upstream of this pathway in the TLR signaling pathway and 
determine whether caveolae are vital for TLR9 clustering and subsequent downstream 
signaling.  
 The amino acid sequence of antiviral toll-like receptors TLR3, TLR7, and TLR9 
were analyzed for caveolin-binding motifs. Out of these TLRs, only TLR9 contained a 
caveolin-binding motif, which is present in most caveolae-associated proteins. The 
sequences ΦXΦXXXXΦ and ΦXXXXΦXXΦ (Φ = Trp, Phe, or Tyr) are present in these 
proteins. I discovered two caveolin-binding motifs in TLR9 transcripts, FYFSMWHF and 
FLFPKFKY (Fig. 15). One of these caveolin-binding motifs (FYFSMWHF) resides 
between two LRR domains in the TLR9 transcript. This caveolin-binding motif may play 
a critical role in proper ligand recognition, as the leucine-rich repeats (LRR) of the TLR 
is necessary for pathogen recognition. The other motif (FLFPKFKY) resides in the TIR 
domain of TLR9. This caveolin-binding motif may play a vital role in the association of 
the TIR domains of MyD88 and TLR9 and the initiation of signal transductions. 
Aromatic residues are vital for proper recognition of the caveolin-binding motif. Since 
TLR9 has these two caveolin-binding motifs, I suspect that TLR9 interacts with caveolin. 
Thus, caveolae may be vital for TLR9 signaling. Viral modulation of caveolae may 
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therefore be a two-pronged approach for evasion of IFN production. This hypothetical 
interaction is what led me to the present study, predicting a role for caveolin in the TLR9 
pathway. Interestingly in the zebrafish, the amino acid sequence for CRFB1, a 
component of the IFNR complex, also possesses a caveolin-binding motif (Gabor et al., 
Submitted). 
 Since TLR9 is an endosomal receptor, it was of interest to determine the location 
of TLR9. After overexpressing Rab7-PA-mCherry and TLR9-dendra2 in ZFL cells, 
confocal images illustrated colocalization of these two molecules (Fig. 16). Since TLR9-
dendra2 is located in the endosome, it could be demonstrated through single-color and 
two-color FPALM imaging that TLR9 molecules were present in the endosome. In the 
FPALM images, each green dot represents a single TLR9 molecule (Fig. 17). Single-
color of TLR9-dendra2 only and two-color FPALM of TLR-dendra2 co-transfected with 
Cav-1b-PA-mCherry permits visualization of TLR9, either in clusters or randomly 
distributed in the endosome. In this way, it is possible to ascertain visually whether TLR9 
forms clusters and colocalizes with caveolin. 
 In order for TLR9 to signal efficiently, clustering of these receptors in the 
endosome is necessary. I want to investigate the role of caveolin in the clustering and 
function of these receptors. Single-color FPALM of TLR9-dendra2 overexpressed in ZFL 
cells without ligand stimulation illustrated such clustering. Of the 1573 single molecules 
of TLR9 imaged (Fig. 17), pair correlation statistical analysis generated a g(r) value of 
2.4, which means that the TLR9 molecules were not randomly distributed, and instead 
were clustered. If TLR9 receptors were not clustered within caveolae membrane 
domains, there would not have been efficient downstream signaling from this pathway. 
42 
 
 
The concentration of TLR9 into clusters is due to the organization of these caveolae 
membrane domains. TLR9 forms clusters in the endosome without ligand stimulation and 
these clusters should be dispersed during viral infection. I hypothesize that viruses are not 
only able to disrupt caveolae membrane domains at the cellular membrane, where the 
IFNRs are positioned and clustered (Gabor et al., Submitted), but also at the endosomal 
membrane, where the TLR9 receptors are positioned and clustered. 
 Since TLR9 transcripts contain two caveolin-binding motifs, it is possible that 
caveolae are critical for TLR9 signaling. After confirming that TLR9 clusters in the 
endosome, I want to determine whether caveolin and TLR9 indeed colocalize. Through 
two-color FPALM imaging, colocalization of the two species, shown as regions of yellow 
(Fig. 18), is demonstrated. It has not been shown previously that TLR9 and caveolin 
colocalize in the endosome of zebrafish. This finding implies that TLR9 and caveolin are 
interacting in the endosome. If caveolin is downregulated, caveolae membrane domains 
are disrupted and clusters of TLR9 are dispersed. As a result, downstream signaling of 
the TLR9 pathway is dampened. This suggests a role for caveolae, not only in the IFNR 
pathway, but the TLR pathway as well. Thus, viruses may be circumventing two 
important antiviral innate immune responses. 
 Since colocalization of TLR9 and caveolin had now been shown, the next step 
was to study the effects of depleting caveolin on TLR9 signaling. Upon activation of 
TLR9 with unmethylated CpG DNA (i.e., CpG 1668), the TLR signaling pathway is 
initiated (Fig. 9), and IFN expression is induced. IFN is secreted and binds to the IFNR 
on neighboring cells, initiating a second signal transduction pathway (Fig. 10). This 
pathway ultimately leads to the activation of antiviral genes vital for inducing the 
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antiviral state. In this antiviral state, virus replication is blocked (Fig. 6). Even so, viruses 
have evolved ways to evade such host antiviral immune response. Our lab has shown 
previously that viruses modulate caveolae, leading to the disruption of IFNR clusters 
(Gabor et al., Submitted). The aim of the present study is to examine how modulating 
caveolae affects clusters of TLR9. The extent of IFN induction was quantified via a Dual-
Luciferase Reporter Assay (Fig. 19). The value of relative luminescence units (RLU) is 
directly related to the level of IFN activity. The control ZFL cells illustrate how TLR9 
would normally respond to unmethylated CpG DNA in cells with normal expression of 
caveolin and thus intact caveolae membrane domains. When stimulated by the 
appropriate ligand, IFN is induced significantly, but in Cav-1b depleted ZFL cells, the 
level of IFN induction from ligand stimulation was not significantly induced, and it is 
instead comparable to unexposed ZFL cells. I demonstrated that TLR9 forms clusters and 
colocalizes with caveolin so I can postulate that caveolae are needed to maintain TLR9 
clusters. This suggests a role for caveolae in clustering TLR9 receptors for IFN induction 
through the TLR9 signaling pathway. 
 In this study, I demonstrate that TLR9 and caveolin colocalize in the endosome. I 
show that as a result of depleting caveolin, IFN expression via TLR9 is dampened upon 
ligand stimulation, suggesting a role for caveolin in the TLR9 signaling pathway. 
 Since it has now been shown that TLR9 and caveolin colocalize and I have also 
demonstrated that caveolae are vital for TLR9 signaling, I hypothesize that fewer TLR9 
molecules will be observed by FPALM if Cav-1 is depleted, and that the clusters of 
TLR9 molecules will be dispersed. 
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 Having elucidated two caveolin-binding motifs for TLR9, I anticipate the 
discovery of the protein-protein interactions between TLR9 and Cav-1 using biochemical 
techniques. Western blot analysis will determine if this interaction indeed exists and site-
specific mutagenesis of the caveolin-binding motif in TLR9 transcripts, western blot 
and/or FPALM imaging can report whether the two proteins no longer interact or 
colocalize. 
 The majority of experiments discussed up to this point have been performed in 
vitro in ZFL cells. It will be interesting to explore these same processes in vivo in the 
zebrafish by depleting TLR9 with a TLR9 MO, followed by exposure to unmethylated 
CpG DNA or live bacteria such as Pseudomonas aeruginosa or Edwardsiella tarda. 
 In conclusion, previous studies show that upon viral infection, caveolin transcripts 
are downregulated, clusters of IFNRs are dispersed, and antiviral immune responses are 
abrogated (Gabor et al., Submitted). I want to understand further the role of caveolin 
upstream in the TLR signaling pathway. Our lab has demonstrated that upon viral 
infection or ligand exposure, depletion of caveolin and the disruption of caveolae 
membrane domains leads to dampened IFN production in addition to dispersed IFNRs 
(Gabor et al., Submitted) and possibly TLRs. Thus, viruses are evading not just one, but 
two important host antiviral innate immune responses. Understanding the mechanisms by 
which viruses are evading the host’s immune system will prove to be important in the 
study and the development of new and effective targeted treatments, such as IFN and 
TLR antiviral therapies. 
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